Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nutanix

Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022

Why Nutanix Shares Are Plummeting After Hours

Why Nutanix Shares Are Plummeting After Hours

Nutanix Inc (NASDAQ: NTNX) reported third-quarter rev

Nutanix: Q3 Earnings Insights

Nutanix: Q3 Earnings Insights

Nutanix (NASDAQ:NTNX) reported its Q3 earnings results on Wednesday, May 25, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Nutanix beat estimated earnings by 77.27%, reporting an EPS of $-0.05 versus an estimate of $-0.22.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Earnings Outlook For Nutanix

Nutanix (NASDAQ:NTNX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-25. Here's what investors need to know before the announcement. Analysts estimate that Nutanix will report an earnings per share (EPS) of $-0.22.

VMware vs. Nutanix: Which Stock is a Better Buy?

Because the software industry is booming with continued digital transformation and hybrid activities, prominent companies in this space, VMware (VMW) and Nutanix (NTNX), should witness increasing demand for their solutions. But which of these two stocks is a better buy now? Read on to learn our view.

Recap: Nutanix Q2 Earnings

Nutanix (NASDAQ:NTNX) reported its Q2 earnings results on Wednesday, March 2, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Nutanix beat estimated earnings by 84.21%, reporting an EPS of $-0.03 versus an estimate of $-0.19.

Nutanix's Earnings: A Preview

Nutanix (NASDAQ:NTNX) is set to give its latest quarterly earnings report on Wednesday, 2022-03-02. Here's what investors need to know before the announcement. Analysts estimate that Nutanix will report an earnings per share (EPS) of $-0.19.

inkl

Read news from The Economist, FT, and more,
with one subscription

Where Nutanix Stands With Analysts

Where Nutanix Stands With Analysts

Analysts have provided the following ratings for Nutanix (NASDAQ:NTNX) within the last quarter:

Here's Why KeyBanc Sees 39% Upside In Nutanix

Here's Why KeyBanc Sees 39% Upside In Nutanix

KeyBanc analyst Thomas Blakey initiated coverage of Nutanix Inc (NASDAQ:NTNX) with an Overweight rating and a $39 price target, suggesting an upside of 38.74%. The recent acceleration, new product cross-sell, and go-to-market partnerships have influenced his above-Street revenue and ACV billings outlook. Blakey further notes that he sees potential rerating with about 50% of…

Organisations

Cardinal Health

B of A Securities

Dick Sporting Goods

Lululemon Athletica

Evercore ISI Group

AmerisourceBergen

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play